TENON MEDICAL INC (TNON)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-09
$2.44-27.38%
Close 2026-09-09 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-09
Broken: Primary pillar broken — Sustain revenue growth near $1.47 million quarterly: rev $1.3M vs $1.47M target.
Tenon Medical raised $4.2 million to support growth. Revenue nearly doubled to $1.47 million in 2025. The company aims to meet Nasdaq listing rules. These steps could stabilize the business.
The company is still losing money with negative EPS. Revenue growth is weak and volatile. Nasdaq delisting risk remains. The recent sharp stock selloff shows investor doubts.
The market is selling off sharply, reflecting concerns about the company’s losses and listing risks. The price likely prices in continued financial struggles and uncertain recovery.
Breaks if: Fails to secure additional financing to support growth
Breaks if: Failure to meet Nasdaq listing requirements
quarterly revenue falls below $1.38 million
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a speculative growth opportunity. The company is currently loss-making and has shown volatile management performance, which adds to the uncertainty of its long-term prospects.
The market appears to be pricing in a high level of risk due to the company's recent earnings misses and loss-making status. Expectations may be tempered as the Street tends to lower estimates when guidance is cut.
Management has prioritized revenue growth and improving financial results, with recent quarters showing strong revenue increases and margin improvements. However, there is a high probability of an earnings miss in the near term, which could impact investor sentiment.
The long-term thesis hinges on the company's ability to maintain revenue growth and manage expenses effectively. Additionally, the performance of sector leaders and overall economic conditions, such as job growth, will be critical in shaping future outcomes.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. The company raised $3 million in a private placement. This gives it more financial headroom for operations. However, earnings missed estimates, indicating challenges in revenue growth.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Over the next 1 to 3 years, TNON's trajectory will depend on its operational execution and external market conditions. Not investment advice.